par Matikas, Alexios;Naume, Bjorn;Wildiers, Hans;Sonke, Gabe GS;Dieci, Maria Vittoria;Karakatsanis, Andreas;Andersson, Anne;Barnekow, Elin;Kessler, Luisa Edman;Einbeigi, Zakaria;Killander, Fredrika;Linderholm, Barbro B.K.;Schiza, Aglaia;Valachis, Antonis;Nearchou, Andreas;Engebraaten, Olav;Porojnicu, Alina;Soland, Mari Hiorth;Mannsåker, Bård;Raj, Sunil Xavier;Blix, Egil Støre;Nordstrand, Cecilie Soma;Lambertini, Matteo;Vernieri, Claudio;Punie, Kevin;Sotiriou, Christos
;Bergh, Jonas;Villacampa, Guillermo;Zouzos, Athanasios;Hellström, Mats;Hartman, Johan;Foukakis, Theodoros
Référence BMJ open, 15, 8, page (e102626)
Publication Publié, 2025-08
;Bergh, Jonas;Villacampa, Guillermo;Zouzos, Athanasios;Hellström, Mats;Hartman, Johan;Foukakis, TheodorosRéférence BMJ open, 15, 8, page (e102626)
Publication Publié, 2025-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Matikas, Alexios; Naume, Bjorn; Wildiers, Hans; Sonke, Gabe GS; Dieci, Maria Vittoria; Karakatsanis, Andreas; Andersson, Anne; Barnekow, Elin; Kessler, Luisa Edman; Einbeigi, Zakaria; Killander, Fredrika; Linderholm, Barbro B.K.; Schiza, Aglaia; Valachis, Antonis; Nearchou, Andreas; Engebraaten, Olav; Porojnicu, Alina; Soland, Mari Hiorth; Mannsåker, Bård; Raj, Sunil Xavier; Blix, Egil Støre; Nordstrand, Cecilie Soma; Lambertini, Matteo; Vernieri, Claudio; Punie, Kevin; Sotiriou, Christos; Bergh, Jonas; Villacampa, Guillermo; Zouzos, Athanasios; Hellström, Mats; Hartman, Johan; Foukakis, Theodoros |
| Informations sur la publication: | BMJ open, 15, 8, page (e102626) |
| Statut de publication: | Publié, 2025-08 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Breast tumours |
| Clinical trials | |
| Drug Therapy | |
| MeSH keywords: | Female |
| Humans | |
| Antibodies, Monoclonal, Humanized -- therapeutic use -- administration & dosage | |
| Antineoplastic Agents, Immunological -- therapeutic use | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Breast Neoplasms -- drug therapy -- metabolism | |
| Carboplatin -- administration & dosage -- therapeutic use | |
| Clinical Trials, Phase II as Topic | |
| Docetaxel -- administration & dosage | |
| Immunoconjugates -- therapeutic use -- administration & dosage | |
| Neoadjuvant Therapy -- methods | |
| Paclitaxel -- administration & dosage -- therapeutic use | |
| Randomized Controlled Trials as Topic | |
| Receptor, ErbB-2 -- metabolism | |
| Trastuzumab -- therapeutic use -- administration & dosage | |
| Multicenter Studies as Topic | |
| Camptothecin -- analogs & derivatives | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:2044-6055 |
| info:doi/10.1136/bmjopen-2025-102626 | |
| info:pii/bmjopen-2025-102626 | |
| info:pmid/40866060 | |
| PMC12410627 |



